Kevin B. Espinola

Partner

SAP AG acquires Sybase for $5.8 billion
Jones Day advised SAP AG in its $5.8 billion agreement to acquire Sybase, Inc., an enterprise software and services company.

Celgene to acquire Abraxis BioScience for $2.9 billion
Jones Day advised Celgene Corporation in reaching a merger agreement with Abraxis BioScience Inc. for $2.9 billion.

Virage Logic acquired by Synopsys for $315 million
Jones Day is advising Virage Logic Corporation in its $315 million acquisition by Synopsys, Inc.

Bell Microproducts to be acquired by Avnet for $594 million
Jones Day advised Bell Microproducts, Inc. in its $594 million acquisition by Avnet, Inc. Founded in 1988, Bell, with sales of approximately $3.0 billion in calendar year 2009, is a leading value-added distributor of storage and computing technology.

BioMarin acquires LEAD Therapeutics
Jones Day advised BioMarin Pharmaceutical, Inc. in connection with the acquisition of LEAD Therapeutics, Inc., a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.

Celgene buys Gloucester Pharmaceuticals for $640 million to bolster its anticancer drug pipeline
Jones Day advised Celgene Corporation in its acquisition of Gloucester Pharmaceuticals.

The following represents experience prior to joining Jones Day.

Public Company Mergers

• Amgen Inc., in connection with its acquisition of Immunex Corporation ($16 billion)
• Amgen Inc., in connection with its acquisition of Tularik, Inc. ($1.3 billion)
• Axon Instruments, Inc., in connection with its sale to Molecular Devices Corporation ($140 million)
• Axonyx, Inc., in connection with its sale to TorreyPines Therapeutics, Inc. ($80 million)
• CIMA Labs Inc., in its terminated merger-of-equals transaction with aaiPharma Inc. ($900 million, combined value)
• CIMA Labs Inc., in connection with the sale of the company to Cephalon, Inc. ($515 million)
• FileNet Corporation, in connection with its sale to IBM ($1.6 billion)
• First Consulting Group, in connection with its sale to Computer Sciences Corporation ($365 million)
• Harrah’s Entertainment, Inc., in connection with its acquisition of Caesars Entertainment, Inc. ($9.44 billion)
• Controlling stockholders of Hydril Corporation, in connection with the sale of the company to Tenaris S.A. ($2.16 billion)
• ICOS Corporation, in connection with the sale of the company to Eli Lilly & Company ($2.3 billion)
• InSight Health Services Corp., in connection with the sale of the company to J.W. Childs Associates, L.P. and The Halifax Group, L.L.C. ($450 million) (represented special committee and the company)
• Interpore International, Inc., in connection with its sale to Biomet, Inc. ($280 million)
• IsoTis Inc., in connection with the sale of the company to Integra Life Sciences Holding Corporation ($51 million)
• Medicis Pharmaceutical Corporation, in connections with its terminated acquisition of Inamed Corporation ($2.8 billion)
• Medicis Pharmaceutical Corporation, in connections with the successful defense against hostile bid made by Mentor Corporation
• Micro Therapeutics, Inc, in connection with the sale of the company to its controlling stockholder, ev3 Inc. (represented special committee)
• Ortel Corporation, in connection its acquisition by Lucent Technologies Inc. ($2.95 billion)
• PIMCO Advisors, L.P., in connection with its acquisition of Oppenheimer Capital ($265 million)
• The Sands Regent, in connection with the sale of the company to Herbst Gaming, Inc. ($148 million)
• Tuboscope, Inc., in connection with its merger-of-equals with Varco International, Inc. ($1.8 billion, combined value)
• Varco International, Inc, in connection with its merger-of-equals with National-Oilwell, Inc. ($5 billion, combined value)
• Watson Pharmaceutical, Inc. in connection with its acquisition of Andrx Corporation ($1.9 billion)

• Advantage Sales & Marketing, LLC, in connection with its recapitalization and acquisition of a majority interest by Allied Capital Corporation
• Ambassadors International, Inc., in connection with its acquisition of Bellingham Marine Industries, Inc. from Nishida Tekko Corporation
• Ambassadors International, Inc., in connection with its acquisition of Newport Harbor Shipyard II, Inc.
• Ambassadors International, Inc., in connection with its acquisition of BellPort Group, Inc. (represented special committee and company)
• Ambassadors International, Inc., in connection with its acquisition of BellJa Holding Company, Inc.
• Complete Production Services, in connection with its acquisition of Pumpco Services, Inc.
• Harrah’s Entertainment, Inc., in connection with its acquisitions of Horseshoe Gaming Holding Corp.
• Innovent Systems, Inc., in connection with the sale of the company to Broadcom Corporation